Suprax 400 mg 5 capsules
Tradename
Suprax
Suprax
Composition
Each capsule contains:
Cifixime 400 mg
Properties
Semi-synthetic cephalosporin antibiotic of the third generation for oral administration with a wide spectrum of action. It has a bactericidal effect. The mechanism of action is due to the inhibition of the synthesis of the cell membrane of the pathogen. Cefixime is resistant to ßlactamases produced by most gram-positive and gram-negative bacteria.
In vitro cefixime is active against gram-positive bacteria: Streptococcus agalactiae; gramnegative bacteria: Haemophilus parainfluenzae, Proteus vulgaris, Klebsiella pneumoniae, Klebsiella oxytoca, Pasteurella multocida, Providencia spp., Salmonella spp., Shigella spp., Citrobacter amalonaticus,
Citrobacter diversus, Serratia marcesceus
Indications
Infectious and inflammatory diseases caused by sensitive microorganisms: pharyngitis, tonsillitis, sinusitis, acute and chronic bronchitis, otitis media, uncomplicated urinary tract infections, uncomplicated gonorrhea.
Method of administration and dosage:
For adults and children over 12 years old with a body weight of more than 50 kg, the daily dose is 400 mg (1 time / day or 200 mg 1 time / day). The duration of the course of treatment is 7-14 days. For uncomplicated gonorrhea 400 mg once.
Contraindications
Hypersensitivity to cephalosporins and penicillins.
Precautions:
It should be used with caution in elderly patients, patients with chronic renal failure or pseudomembranous colitis (in history), in children under 6 months of age.
Side effects
From the digestive system: dry mouth, anorexia, diarrhea, nausea, vomiting, abdominal pain, flatulence, transient increase in the activity of hepatic transaminases and alkaline phosphatase, hyperbilirubinemia, jaundice, gastrointestinal candidiasis, dysbiosis; rarely — stomatitis, glossitis, pseudomembranous enterocolitis.
From the hematopoietic system: leukopenia, thrombocytopenia, neutropenia, hemolytic anemia.
From the side of the central nervous system: dizziness, headache.